comparemela.com

Latest Breaking News On - Pamela keck - Page 2 : comparemela.com

Medigene AG Extends Cash Runway into July 2025 After Successful Oversubscribed Capital Raise

Medigene AG Extends Cash Runway into July 2025 After Successful Oversubscribed Capital Raise
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Pamela-keck
Planegg-martinsried
Cash-runway
Successful-oversubscribed-capital
Prime-standard
End-to-platform

Medigene to Present at Upcoming Conferences

Medigene to Present at Upcoming Conferences
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

Germany
Anne-wiebe-mohr
Planegg-martinsried
Doloresj-schendel
Melanie-salvermoser
Dominik-alterauge
Julia-bittmann
Maja-buerdek
Petrau-prinz
Giulia-longinotti
Fotini-vogiatzi
Doris-brechtefeld

Medigene Presents Superior TCR-T Cell Functionality by Inclusion of a Costimulatory Switch Protein

Planegg/Martinsried, May 2, 2024. Medigene AG , an immuno-oncology platform company focusing on the discovery and development of T cell immunotherapies for solid tumors, presented superior T cell.

Netherlands
Amsterdam
Noord-holland
Pamela-keck
Planegg-martinsried
International-neoantigen-summit
Prime-standard
Improved-multi-functionality
Costimulatory-switch
Chief-executive-officer
End-to-platform
Programmed-death-ligand

Medigene AG Expands Patent Portfolio with European Patent Grant for its NY-ESO-1

Medigene AG Expands Patent Portfolio with European Patent Grant for its NY-ESO-1
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United-states
New-york
Taiwan
South-korea
Japan
Australia
Experte-carsten-stork
Planegg-martinsried
Zwei-rohstoff-chancen
Pamela-keck
European-patent-office
Prime-standard

Medigene AG Expands Patent Portfolio with European Patent Grant for its NY-ESO-1 – targeted T ...

Planegg/Martinsried, May 2, 2024. Medigene AG (Medigene or the “Company”, FSE: MDG1, Prime Standard), an immuno-oncology platform company focusing on the discovery and development of T cell immunotherapies for solid

Australia
Japan
United-states
South-korea
New-york
Taiwan
Pamela-keck
Planegg-martinsried
European-patent-office
Prime-standard
End-to-technology
End-to-platform

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.